The preliminary data was accepted as a late breaking abstract. If it did not include efficacy results the scientific world needs to know about, it would not fulfil the criteria in this category. All current study arms in the DIPG combo PNOC trial include paxalisib and ONC201 in different treatment patterns.
KZA Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held